Posted By John Morris On 3 Feb 2026 Comments (0)
The FDA now conducts unannounced inspections of foreign drug factories making generics for the U.S. market. With 80% of active ingredients coming from India and China, stricter oversight is reducing contamination, falsified records, and safety risks. What this means for patients.
READ MORE